Inhibrx Biosciences  logo

Inhibrx Biosciences share price today

(INBX)

Inhibrx Biosciences share price is $14.49 & ₹1,234.52 as on 25 Dec 2024, 2.30 'hrs' IST

$14.49

0.02

(0.14%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Inhibrx Biosciences share price in Dollar and Rupees. Guide to invest in Inhibrx Biosciences from India. Also see the sentimental analysis on Indian investors investing in Inhibrx Biosciences . Get details on the Indian mutual funds that are investing in Inhibrx Biosciences . Get Analyst recommendations and forecasts along with all the Inhibrx Biosciences 's financials.

Inhibrx Biosciences share price movements

  • Today's Low: $14.11
    Today's High: $14.68

    Day's Volatility :3.89%

  • 52 Weeks Low: $10.80
    52 Weeks High: $39.79

    52 Weeks Volatility :72.86%

Inhibrx Biosciences Returns

PeriodInhibrx Biosciences, Inc. Sector (Health Care)Index (Russel 2000)
3 Months
-5.48%
-9.0%
0.0%
6 Months
3.06%
-4.6%
0.0%
1 Year
-57.94%
3.0%
0.0%
3 Years
-67.84%
0.0%
-21.1%

Inhibrx Biosciences Key Statistics

in dollars & INR

Previous Close
$14.47
Open
$13.94
Today's High
$14.68
Today's Low
$14.1091
Market Capitalization
$209.8M
Today's Volume
$51.6K
52 Week High
$39.79
52 Week Low
$10.8
Revenue TTM
$1.7M
EBITDA
$-300.9M
Earnings Per Share (EPS)
$119.39
PE Ratio
0.12
Profit Margin
101974.22%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-2031.05%

How to invest in Inhibrx Biosciences from India?

It is very easy for Indian residents to invest directly in Inhibrx Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Inhibrx Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Inhibrx Biosciences or INBX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Inhibrx Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Inhibrx Biosciences shares which would translate to 0.059 fractional shares of Inhibrx Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Inhibrx Biosciences , in just a few clicks!

Returns in Inhibrx Biosciences for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Inhibrx Biosciences investment value today

Current value as on today

₹44,300

Returns

₹55,700

(-55.7%)

Returns from Inhibrx Biosciences Stock

₹57,939 (-57.94%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Inhibrx Biosciences

0%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Inhibrx Biosciences on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 0% more investors are searching Inhibrx Biosciences in the last 30 days versus the previous period.

Global Institutional Holdings in Inhibrx Biosciences

    Analyst Recommendation on Inhibrx Biosciences

    Hold

      0%Buy

      62%Hold

      37%Sell

    Based on 8 Wall street analysts offering stock ratings for Inhibrx Biosciences (by analysts ranked 0 to 5 stars)

    Based on 8 analyst
    • Current
    • 1M Ago
    • 3M Ago
    Buy
    0
    0
    6
    Hold
    5
    5
    3
    Sell
    3
    3
    0

    Analyst Forecast on Inhibrx Biosciences

    What analysts predicted

    Upside of 3.52%

    Current:

    $14.49

    Target:

    $15.00

    Insights on Inhibrx Biosciences

    • Price Movement

      In the last 1 year, INBX stock has moved down by -56.9%
    • Decreasing Revenue

      Revenue is down for the last 2 quarters, 1.63M → 100.0K (in $), with an average decrease of 93.9% per quarter
    • Decreasing Net Profit

      Netprofit is down for the last 2 quarters, 1.85B → -43.86M (in $), with an average decrease of 102.4% per quarter
    • INBX vs ALNY (1 yr)

      In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 84.1%
    • INBX vs VRTX (3 yr)

      In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 92.6%
    • Price to Sales

      ForINBX every $1 of sales, investors are willing to pay $123.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

    Inhibrx Biosciences Technicals Summary

    Sell

    Neutral

    Buy

    Inhibrx Biosciences is currently in a neutral trading position according to technical analysis indicators.

    Inhibrx Biosciences Vs Peers

    Company Name1 Month6 Month1 Year3 Years5 Years
    Inhibrx Biosciences, Inc.
    -6.21%
    3.06%
    -57.94%
    -67.84%
    -29.76%
    Regeneron Pharmaceuticals, Inc.
    -5.12%
    -32.01%
    -18.29%
    12.56%
    91.19%
    Biontech Se
    -3.72%
    41.99%
    6.11%
    -55.22%
    226.93%
    Alnylam Pharmaceuticals, Inc.
    -3.99%
    -1.52%
    23.75%
    50.98%
    112.09%
    Vertex Pharmaceuticals Incorporated
    -12.61%
    -13.61%
    0.03%
    83.58%
    86.41%
    Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
    Inhibrx Biosciences, Inc.
    0.12
    0.12
    NA
    102.04
    -20.31
    -0.57
    NA
    15.15
    Regeneron Pharmaceuticals, Inc.
    17.67
    17.67
    1.06
    45.07
    0.17
    0.07
    NA
    272.04
    Biontech Se
    160.8
    NA
    0.04
    -3.11
    -0.02
    -0.01
    NA
    79.73
    Alnylam Pharmaceuticals, Inc.
    NA
    NA
    -0.49
    -0.19
    -15.01
    -0.03
    NA
    0.25
    Vertex Pharmaceuticals Incorporated
    32.84
    NA
    1.06
    0.51
    -0.03
    0.12
    NA
    60.65
    Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
    Inhibrx Biosciences, Inc.
    Hold
    $209.8M
    -29.76%
    0.12
    101974.22%
    Regeneron Pharmaceuticals, Inc.
    Buy
    $78.5B
    91.19%
    17.67
    33.61%
    Biontech Se
    Buy
    $27.4B
    226.93%
    160.8
    -15.36%
    Alnylam Pharmaceuticals, Inc.
    Buy
    $31.4B
    112.09%
    NA
    -15.86%
    Vertex Pharmaceuticals Incorporated
    Buy
    $105.1B
    86.41%
    32.84
    -4.51%

    About Inhibrx Biosciences

    Organization
    Inhibrx Biosciences
    Employees
    166
    CEO
    Mr. Mark Paul Lappe
    Industry
    Health Technology

    Management People of Inhibrx Biosciences

    NameTitle
    Mr. Mark Paul Lappe
    CEO, President & Chairman
    Ms. Kelly Devine Deck B.S., CPA, M.S.
    Executive VP, CFO & Treasurer
    Ms. Bonne Adams M.B.A.
    Vice President of Operations
    Dr. Ashraf Amanullah Ph.D.
    Executive VP, Chief Technical Operations Officer
    Dr. Brendan P. Eckelman Ph.D.
    Executive VP & Chief Scientific Officer
    Ms. Leah Pollema J.D.
    VP & General Counsel
    Dr. Charbel Helaihel Pharm.D.
    Vice President of Marketing & Commercial Planning
    Mr. Jeffrey J. Jensen
    Executive VP & Chief Clinical Operations Officer
    Dr. Josep Garcia Ph.D.
    Executive VP & Chief Clinical Development Officer
    Mr. David Matly M.B.A.
    Executive VP and Chief Commercial & Business Development Officer

    Important FAQs about investing in Inhibrx Biosciences from India :

    What is Inhibrx Biosciences share price today?

    Inhibrx Biosciences share price today stands at $14.49, Open: $13.94 ; Previous Close: $14.47 ; High: $14.68 ; Low: $14.11 ; 52 Week High: $39.79 ; 52 Week Low: $10.80. The stock opens at $13.94, after a previous close of $14.47. The stock reached a daily high of $14.68 and a low of $14.11, with a 52-week high of $39.79 and a 52-week low of $10.80.

    Can Indians buy Inhibrx Biosciences shares?

    Yes, Indians can invest in the Inhibrx Biosciences (INBX) from India.

    With INDmoney, you can buy Inhibrx Biosciences at 0 brokerage. The step-by-step process is as follows:

    • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
    • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
    • Once funds are transferred successfully, you can buy Inhibrx Biosciences at zero transaction cost.

    How can I buy Inhibrx Biosciences shares from India?

    It is very easy to buy Inhibrx Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

    Can Fractional shares of Inhibrx Biosciences be purchased?

    Yes, you can buy fractional shares of Inhibrx Biosciences with INDmoney app.

    What are the documents required to start investing in Inhibrx Biosciences stocks?

    To start investing in Inhibrx Biosciences , You will need the following documents:

    • Proof of Identification (PAN, Aadhaar etc)
    • Proof of address (Aadhaar, Voter ID etc)

    These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

    What are today’s High and Low prices of Inhibrx Biosciences

    Today’s highest price of Inhibrx Biosciences (INBX) is $14.68.

    Today’s lowest price of Inhibrx Biosciences (INBX) is $14.11.

    What is today's market capitalisation of Inhibrx Biosciences

    Today's market capitalisation of Inhibrx Biosciences INBX is 209.8M

    What is the 52 Week High and Low Range of Inhibrx Biosciences

    • 52 Week High

      $39.79

    • 52 Week Low

      $10.80

    What are the historical returns of Inhibrx Biosciences ?

    • 1 Month Returns

      -6.21%

    • 3 Months Returns

      3.06%

    • 1 Year Returns

      -57.94%

    • 5 Years Returns

      -29.76%

    Who is the Chief Executive Officer (CEO) of Inhibrx Biosciences

    Mr. Mark Paul Lappe is the current Chief Executive Officer (CEO) of Inhibrx Biosciences .